According to the report published by Allied Market Research, the global stem cell therapy market generated $205.1 million in 2021, and is expected to reach $928.6 million by 2031, manifesting a CAGR of 16.2% from 2022 to 2031. The report offers an extensive analysis of changing market dynamics, top segments, value chain, competitive landscape, and the Covid-19 pandemic impact. This report provides detailed information for market players, stakeholders, investors, and startups to help them devise strategies for gaining competitive edge and sustainable growth.
Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/11317
Covid-19 Scenario:
- The Covid-19 pandemic made a negative impact on the stem cell therapy market, owing to disruptions and complexities in supply chain, manufacturing, and logistics processes. The costs and reimbursements related to the stem cell therapy were surged during the pandemic, owing to the lockdown restrictions imposed during pandemic.
- The research and development activities were affected during the pandemic due to lockdown restrictions and lack of new investments. Many investors froze the investments for the uncertain period of time to cope up with the economic uncertainties.
- Many medical procedures involving stem cell therapy were postponed due to focus on treatment of the Covid-infected patients and shift in hospital resources to Covid wards.
The research provides detailed segmentation of the global steam cell therapy market based on cell source, application, type, and region. The research discusses segments along with their sub-segments to identify the largest revenue-generating and fastest-growing segments for market players and startups. Market size and estimations for each segment and its sub-segment are offered in the report to identify the steps that can be adopted for achieving the growth.
Based on cell source, the adipose tissue-derived mesenchymal stem cells segment held the highest share in 2021, accounting for more than half of the total share, and is projected to continue its leadership status during the forecast period. However, the bone marrow-derived mesenchymal stem cells segment is expected to manifest the highest CAGR of 16.9% from 2022 to 2031.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/11317
Based on application, the cancer segment accounted for the highest share in 2021, contributing to nearly half of the global stem cell therapy market, and is projected to maintain its lead in terms of revenue during the forecast period. Moreover, this segment is expected to manifest the highest CAGR of 16.8% from 2022 to 2031. The report also analyzes the segments including musculoskeletal disorder, wounds and injuries, cardiovascular disease, and others.
Based on type, the autologous transplants segment contributed to the highest share in 2021, holding more than half of the market, and is expected to dominate in 2031. However, the allogeneic transplants segment is projected to grow at the highest CAGR of 16.4% during the forecast period.
Based on region, North America accounted for the highest share in 2021, holding more than half of the global market, and is expected to maintain its dominance by 2031. However, Asia-Pacific is estimated to grow at the fastest CAGR of 19.0% during the forecast period. The research also analyzes regions including Europe and LAMEA.
Leading market players of the global steam cell therapy market analyzed in the research include Allele Biotechnology and Pharmaceuticals, Inc., Fujifilm Holding Corporation, Astellas Pharma Inc., Novadip Biosciences, Mesoblast Ltd., Orthofix Holdings, Inc., NuVasive, Inc., Takeda Pharmaceutical Company Ltd., Smith & Nephew plc, and U.S. Stem Cell, Inc.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Medical Tourism Market–
https://www.alliedmarketresearch.com/medical-tourism-market
Diabetes Therapeutics Market –https://www.alliedmarketresearch.com/diabetes-therapeutics-market
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com